Basolateral carbonic anhydrase IV in the proximal tubule is a glycosylphosphatidylinositol-anchored protein  by Purkerson, J.M. et al.
Basolateral carbonic anhydrase IV in the proximal
tubule is a glycosylphosphatidylinositol-anchored
protein
JM Purkerson1, AM Kittelberger1 and GJ Schwartz1
1Department of Pediatrics, Strong Children’s Research Center, University of Rochester School of Medicine, Rochester, New York, USA
Carbonic anhydrase (CA) IV facilitates HCO3 reabsorption in
the renal proximal tubule by catalyzing the reversible
hydration of CO2. CAIV is tethered to cell membranes via a
glycosylphosphatidylinositol (GPI) lipid anchor. As there is
basolateral as well as apical CAIV staining in proximal tubule,
the molecular identity of basolateral CAIV was examined.
Biotinylation of confluent monolayers of rat inner medullary
collecting duct cells stably transfected with rabbit
CAIV showed apical and basolateral CAIV, and in the
cell transfectants expressing high levels of CAIV,
a transmembrane form was targeted to the basolateral
membrane. Basolateral expression of CAIV (B46 kDa) was
confirmed in normal kidney tissue by Western blotting of
vesicle fractions enriched for basolateral membranes by
Percoll density fractionation. We examined the mode of
membrane linkage of basolaterally expressed CAIV in the
kidney cortex. CAIV detected in basolateral or apical
membrane vesicles exhibited similar molecular size by
sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis following deglycosylation, and was equally
sensitive to phosphatidylinositol-specific phospholipase C
digestion, indicating that CAIV is expressed on the
basolateral membrane as a GPI-anchored protein. Half of the
hydratase activity of basolateral vesicles was resistant to SDS
denaturation, compatible with being CAIV. Thus,
GPI-anchored CAIV resides in the basolateral membrane of
proximal tubule epithelia where it may facilitate HCO3
reabsorption via association with kNBC1.
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Carbonic anhydrases (CAs) facilitate renal acidification in the
kidney by catalyzing the hydration of CO2 or the reverse
reaction, the dehydration of bicarbonate.1 The majority of
the CA activity in the kidney (B95%) is comprised of
cytosolic CAII.1 CAIV is one of three membrane-associated
CA isoforms,2 the others being CAXII3–7 and in rodent
species, CAXIV,8,9 that account for the remaining CA activity
in the kidney. In humans, rabbits, and rodent species CAIV is
expressed in the proximal tubule (S24S1bS3) and in distal
nephron segments including outer and inner medullary
collecting ducts (IMCDs) and a-intercalated cells of the
cortical collecting duct.1 A major role for CAIV in urinary
acidification has been demonstrated in studies where
inhibition of luminal CA activity eliminates nearly all net
bicarbonate reabsorption in the proximal tubule10 and outer
medullary collecting duct from the inner stripe,11 and in
CAII-deficient patients and mice where inhibition of CA
activity diminishes renal acid secretion.12,13
CAIV is unique among CA isoforms, because it is tethered
to the plasma membrane via a glycosylphosphatidylinositol
lipid anchor (GPI-anchor).14,15 Most GPI-anchored proteins
are targeted to the apical membrane of polarized epithelial
cells;16 nevertheless, CAIV immunoreactivity detected with
different CAIV antibodies has been observed on the
basolateral membranes of proximal tubule segments in
human, rabbit and rodent species.2,17,18 Studies from our
laboratory have functionally demonstrated in the proximal
tubule the existence of a basolateral CA activity that facilitates
fluid and bicarbonate absorption.19 These studies suggested
that either a transmembrane form is expressed basolaterally
or perhaps that GPI-anchored CAIV is additionally targeted
to the basolateral membrane. However, with the recent
description of CAXII as a major CA isoform that is expressed
on the basolateral membranes of acidifying nephron
segments,4 the molecular identity of the basolaterally
expressed CA detected by anti-CAIV antibodies required
investigation.
In this study, we characterized the polarity and the
molecular form of CAIV immunoreactivity in rabbit kidney
cortex and in transfected renal IMCD epithelial cells in
culture. Whereas in IMCD cells overexpressing CAIV, a
transmembrane form is preferentially expressed on the
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basolateral membrane, we found that CAIV is normally
expressed on both the apical and basolateral membranes of
proximal tubule epithelial cells as a GPI-anchored protein.
RESULTS
Trafficking to the basolateral membrane is an intrinsic
property of the CAIV molecule
CAIV is tethered to cell membranes via a GPI anchor, and
typically GPI-anchored proteins are targeted to the apical
membrane of polarized epithelial cells. However, as shown in
Figure 1, immunohistochemical staining of kidney cortex
with antibodies to CAIV consistently showed basolateral
staining of proximal tubules in addition to apical labeling.
The following experiments were designed to determine
whether trafficking to the basolateral membrane of renal
epithelial cells is an intrinsic property of the CAIV molecule,
as well as to ascertain the molecular form of CAIV that is
expressed basolaterally. In initial studies the polarity of CAIV
expression in an in vitro culture model of polarized renal
epithelial cells was examined. IMCD cells were selected for
these studies owing to their ability to form confluent
monolayers with high transepithelial resistance. Confluent
monolayers of IMCD cells stably transfected with a full-
length CAIV exhibiting transepithelial resistance in the range
of 900–1500Ocm2 were subjected to apical and basolateral
surface biotinylation. Biotinylated proteins were precipitated
with streptavidin (SAv)-agarose and levels of CAIV and
apically (GP135) or basolaterally (Naþ ,Kþ -ATPase) ex-
pressed proteins were determined by Western blotting. The
results of three independent biotinylation experiments are
shown in Figure 2a, where GP135 was precipitated pre-
dominantly from cells biotinylated on the apical surface and
Naþ ,Kþ -ATPase was exclusively precipitated from cells
biotinylated on the basolateral side, demonstrating the
specificity of apical versus basolateral surface biotinylation.
CAIV, on the other hand, was equally precipitated from cells
biotinylated on either the apical or basolateral side. These
results demonstrated that CAIV was sorted to both apical and
basolateral membranes of polarized renal epithelial cells.
Because GPI-anchor attachment results in apical sorting
of many proteins in polarized epithelial cells, we examined
whether expression of a transmembrane form of CAIV
explained basolateral expression of CAIV in transfected
IMCD cells. CAIV was subcloned into the pcDNA 3.1 vector
(see Figure 2b), so that CAIV expressed as a transmembrane
protein would contain a 6XHis epitope-tag contiguous with
Figure 1 | CAIV immunoreactivity is observed on the apical and
basolateral membrane of proximal tubules. Paraffin-embedded
sections of rabbit kidney were stained with a goat anti-rabbit CAIV
antibody (YDQR). The slide was developed with an HRP-conjugated
anti-goat antibody utilizing the DAB substrate and counterstained
with hematoxylin. Solid arrows indicate apical staining, whereas
dashed arrows point to basolateral staining. Original magnification
 100.
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Figure 2 | CAIV is expressed on the apical and basolateral
membranes of IMCD transfectants. (a) Confluent monolayers of
IMCD cells stably transfected with rabbit CAIV were grown on
Transwells permeable supports and surface biotinylated on either
the apical or basolateral side. Biotinylated proteins were precipitated
from cell lysates with SAv-agarose. Levels of SAv-precipitated apical
(GP135), basolateral (Naþ ,Kþ -ATPase) proteins, and CAIV were
determined by Western blotting. Results of three independent
surface biotinylation experiments are shown. (b) Rabbit CAIV was
subcloned into the pcDNA 3.1 vector so that CAIV expressed a
transmembrane protein containing the V5-6X His epitope tags.
Omega (o) and (oþ 2) denote the serine residue at which GPI-anchor
attachment occurs and the amino-acid residue that plays a key role in
the efficiency of lipid anchor linkage, respectively. (c) Confluent
monolayers of IMCD cells stably transfected with rabbit CAIV-pcDNA
3.1 construct were surface biotinylated on the apical or basolateral
side. Biotinylated proteins were precipitated from cell lysates with
SAv-agarose or V5-His-tagged proteins with Ni-NTA-agarose. Levels
of transfected CAIV precipitated by Ni-NTA-agarose were determined
by blotting with SAv-HRP, whereas GPI-linked CAIV precipitated with
SAv-agarose was determined by blotting with anti-rabbit CAIV
(KDNV). Results presented in (c) are representative of two
independent experiments.
408 Kidney International (2007) 71, 407–416
o r i g i n a l a r t i c l e JM Purkerson et al.: Basolateral CAIV is GPI-anchored
the COOH-terminal tail region.20 Confluent monolayers
(transepithelial cell resistance ranging from 800 to
1000Ocm2) of IMCD cells stably transfected with CAIV-
pcDNA 3.1 were subjected to surface biotinylation on either
the apical or basolateral side. In the experiment shown in
Figure 2c biotinylated proteins were either precipitated from
solubilized membranes with SAv-agarose and precipitated
CAIV was detected with anti-CAIV antibody by Western
blotting, or alternatively a putative transmembrane form of
CAIV (His-tagged CAIV) was precipitated with Ni-nitrilo-
triacetic acid (NTA)-agarose and subsequently detected by
blotting with SAv conjugated to horseradish peroxidase (SAv-
HRP). Consistent with the experiment shown in Figure 2a,
SAv-agarose precipitated CAIV from membranes subjected to
either apical or basolateral surface biotinylation, indicating
that CAIV was expressed on both membranes. In contrast,
precipitation of a transmembrane form of CAIV with Ni-
NTA occurred predominantly from membranes that had
been biotinylated on the basolateral side. Results presented in
Figure 2c are representative of two independent experiments
and indicate that under conditions of high-level expression in
polarized renal epithelial cells, a portion of CAIV produced is
expressed as a transmembrane protein, and the non-GPI-
linked form of CAIV is preferentially targeted to the
basolateral membrane.
Antibodies to CAIV detect a 46 kDa protein in both apical and
basolateral membranes from kidney cortex
The identity of CAIV immunoreactivity on the basolateral
membrane of renal proximal tubules was examined by
enrichment of basolateral membranes via Percoll density
fractionation of membrane vesicles prepared from kidney
cortex. The levels of apical (NHE3) and basolateral
(Naþ ,Kþ -ATPase) proteins, as well as GPI-anchored pro-
teins (CAIV and alkaline phosphatase) in Percoll gradient
fractions were quantified by Western blotting. As shown in
Figure 3a, fractions 6–10 were enriched for basolateral
membranes, as they contained abundant levels of Naþ ,Kþ -
ATPase, whereas NHE3 was undetectable. Fractions 11–17
contained NHE3 and alkaline phosphatase and exhibited
declining levels of Naþ ,Kþ -ATPase, indicating that these
latter fractions were enriched for apical membrane vesicles.
Antibodies to rabbit CAIV that do not crossreact with
CAXII6 detected a 46 kDa protein across the entire Percoll
density gradient, including fractions enriched for basolateral
membrane vesicles (6–10); thus, CAIV was present in both
apical and basolateral membrane vesicles. This contrasted
with another GPI-anchored protein, alkaline phosphatase,
which clearly exhibited a distribution consistent with apical
expression (Fr. 11–17). Figure 3b shows the average and s.d.
of four independent membrane vesicle fractionations pre-
sented as the percentage of the respective protein total in each
Percoll fraction. Note that alkaline phosphatase co-distrib-
uted with NHE3, whereas CAIV was consistently detected in
basolateral membrane fractions (below 10), characterized by
abundant levels of Naþ ,Kþ -ATPase and low or undetectable
levels of NHE3 and alkaline phosphatase. CAIV in basolateral
membrane fractions (below 10) comprised 31.1712.3% of
the total CAIV content of the Percoll density gradients. These
results confirm that CAIV is expressed on basolateral
membranes of the renal proximal tubule.
CAIV expressed on apical and basolateral membranes is
equally sensitive to cleavage by PI-PLC
To determine whether CAIV is expressed as a GPI-anchored
protein in proximal tubule epithelia, CAIV sensitivity to
cleavage by phosphatidylinositol-specific phospholipase C
(PI-PLC) was examined. In initial studies total membranes
prepared from kidney cortex were subjected to PI-PLC
digestion for 1–4 h, and GPI-anchored protein was
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Figure 3 | Anti-CAIV antibodies detect a 46 kDa protein in both apical and basolateral membrane vesicles. Membrane vesicles prepared
from kidney cortex were fractionated on a Percoll density gradient. Expression of apical (NHE3, alkaline phosphatase) and basolateral
(Naþ ,Kþ -ATPase) membrane proteins and CAIV in the indicated Percoll gradient fractions was determined by Western blotting.
(a) Immunoblots of membrane vesicle fractions containing 25 mg (NHE3), 60 mg (alkaline phosphatase), 0.5 mg (Naþ ,Kþ -ATPase), and
5 mg (CAIV) of total protein. (b) Percentage of total NHE3, alkaline phosphatase, Naþ ,Kþ -ATPase, and CAIV in each Percoll gradient fraction
determined from densitometric scans of four independent experiments. The percentage of total for the respective proteins was
determined by dividing the band intensity for each fraction by the summation of band intensity for all fractions ( 100).
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partitioned from cleaved CAIV by extraction with Triton X-
114. Figure 4a shows the result of one such experiment in
which the levels of GPI-anchored CAIV in the detergent
phase (DG) and cleaved CAIV in the aqueous phase (AQ)
were determined by Western blotting. In the absence of PI-
PLC digestion most of the CAIV partitions into the DG
(89710 %, n¼ 7). It is important to note that Triton X-114
partitioning does not distinguish between transmembrane
and GPI-anchored forms of CAIV, because transmembrane as
well as GPI-anchored proteins partition into the DG.
Following PI-PLC digestion most, but not all, of the CAIV
partitions into the AQ (67714%, n¼ 7), indicative of
removal of the GPI anchor. Despite increasing the length of
PI-PLC digestion from 1–4 h, partitioning of CAIV into the
AQ never approached 100%. Incomplete release of GPI-
anchored proteins from membranes following PI-PLC
treatment is not uncommon,21 and possible explanations
include sequestration into membrane invaginations, localiza-
tion in a lipid environment that prevents PI-PLC access, the
presence of inside-out vesicles, or attachment of CAIV by a
GPI isoform that is resistant to cleavage.
Whether or not the PI-PLC insensitive pool (B30%)
comprised basolateral membrane resident CAIV was exam-
ined by quantifying the PI-PLC sensitivity of CAIV in Percoll-
fractionated membrane vesicles. In the experiment shown in
Figure 4b, total membrane vesicles, basolateral membrane-
enriched fractions (Fr. 6 and 8), or fractions containing
increasing amount of apical vesicles (Fr. 10–14), were
subjected to extensive PI-PLC digestion or left untreated.
Cleaved CAIV was separated from the GPI-anchored protein
by Triton X-114 partitioning. As noted above, in the absence
of PI-PLC digestion CAIV in membrane vesicle fractions
partitioned into the DG phase, whereas PI-PLC treatment
resulted in increased partitioning to the AQ from all
membrane vesicle fractions including fractions enriched
from basolateral membranes (Fr. 6 and 8). Figure 4c shows
the summary of four independent experiments presented as
the fold decrease in partitioning to the DG along with the
fold increase AQ partitioning following PI-PLC digestion.
The decrease in DG CAIV upon PI-PLC digestion in
basolateral fractions 6 and 8 was not significantly different
from that observed in apical fractions (12 and 14; P40.39).
Similarly, the PI-PLC induced increase in AQ CAIV in
basolateral fractions was not different from apical fractions
(P40.32). These data demonstrate that CAIV is expressed on
the apical and basolateral membranes of the proximal tubule
as a GPI-anchored protein. And as CAXII is not a GPI-
anchored protein, cleavage by PI-PLC provides additional
evidence that the basolaterally expressed protein that was
detected by anti-CAIV antibodies is not CAXII.
CAIV is expressed in the kidney cortex as a single molecular
weight species
GPI-anchor attachment occurs at serine residue 280 of CAIV
and results in the removal of 28 amino acids (MW¼ 2870.1)
from the COOH-terminal tail. If CAIV were expressed as
both a GPI-anchored and a transmembrane protein, then two
molecular species of CAIV differing by B3 kDa should exist
in renal epithelial cells.20 To confirm that CAIV is expressed
only as a GPI-anchored protein in the proximal tubule, the
46 kDa
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Figure 4 | CAIV expressed on the apical and basolateral membranes of the proximal tubule are both sensitive to cleavage by PI-PLC.
(a) Membranes (25 mg total protein) prepared from kidney cortex were digested with 500 mU PI-PLC for 1–4 h. GPI-linked/transmembrane
proteins were phase separated from enzymatically cleaved CAIV by extraction with Triton X-114. AQ¼ aqueous phase; DG¼ Triton X-114 phase
DG. (b) The levels of NHE3 and Naþ ,Kþ -ATPase in membrane vesicle fractions determined by Western blotting are shown as a plot
of densitometric scans of film exposures to luminescence. Membrane vesicle fractions were treated with PI-PLC as described or left
untreated (see Materials and Methods) and GPI-anchored/transmembrane proteins were separated from non-GPI-linked protein by Triton
X-114 extraction as in (a). Lower portion of this panel shows levels of CAIV in the AQ and DGs of control and PI-PLC-treated
fractions determined by Western blotting with anti-rabbit CAIV (YDQR). (c) The results of three additional independent experiments
are presented as the mean and s.d. of the fold increase and decrease of CAIV in AQ and DGs, respectively, following PI-PLC digestion
and extraction with Triton X-114. The changes in CAIV partitioning induced by PI-PLC were not significantly different between fractions 6
and 8 and 10 and 12 as determined by two-tailed, Students t-test, assuming equal variance (fold change in AQ P40.31, DG P40.38).
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molecular weight of CAIV peptides in membrane vesicle
fractions isolated from rabbit kidney cortex was examined
following removal of N-linked sugars by treatment with
N-glycanase. As shown in Figure 5, in the absence of
deglycosylation CAIV exhibits an apparent molecular weight
of B46 kDa as determined by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Treatment
of membrane vesicle fractions with N-glycanase reduces the
apparent molecular weight by about 10 kDa, demonstrating
that in contrast to CAIV in human tissue, CAIV is heavily
glycosylated in the rabbit. All of the membrane vesicle
fractions, including total membrane vesicles, contained a
single molecular weight species of deglycosylated CAIV.
Furthermore, there was no apparent difference in the
molecular weight (B35–36 kDa) of deglycosylated CAIV
from basolaterally enriched fractions (Fr. 6 and 8) compared
to fractions containing apical membrane vesicles (Fr. 10–14).
These findings provide additional support for the conclusion
that CAIV is expressed as a GPI-anchored protein on the
basolateral membrane of the proximal tubule. And because
CAXII exhibits a predicited molecular weight of B40 kDa, it
is evident that CAXII is not detected by our antibody against
rabbit CAIV.
CAIV accounts for approximately half of the CA activity in
basolateral membrane of the rabbit proximal tubule
CAXII is another CA isoform that is expressed basolaterally
in the proximal tubule.4 Accordingly, we sought to determine
the extent to which CAIV contributes to hydratase activity in
basolateral membrane vesicles. Owing to the presence of two
disulfide bridges,22 CAIV is resistant to denaturation by
treatment with SDS (0.1–1%), whereas other CA isoforms
expressed in the kidney (CAXII, CAII, and CAXIV in rodent
species) are denatured by SDS treatment.6,23 Therefore,
differential sensitivity to denaturation by SDS was used to
assess the contribution of CAIV to CA hydratase activity in
apical and basolateral membranes of the proximal tubule. CA
hydratase activity in membrane preparations was measured
by a microassay method, as described by Brion et al.24,25 SDS
treatment of total membranes prepared from mouse kidney
cortex reduced hydratase activity by 83%, indicating that CA
isoforms other than CAIV (e.g. CAXII and CAXIV) account
for the bulk of membrane-associated CA activity in mouse
kidney (Table 1, Figure 6b). In contrast, 80–86% of the
hydratase activity in total membrane vesicles isolated from
rabbit kidney cortex was resistant to SDS treatment, in
keeping with our previous study.25 Thus, unlike the mouse,
CAIV accounts for most (80–90%) of the membrane-
associated CA hydratase activity in the rabbit kidney cortex.
To assess the contribution of CAIV to hydratase activity in
apical and basolateral membranes of the proximal tubule, the
microassay method was used to measure CA activity in
vesicles enriched for basolateral or apical membranes by
Percoll density fractionation. As shown in Figure 6a, fractions
6 and 8 contained CAIV-containing vesicles enriched for
basolateral membranes, characterized by abundant Naþ ,Kþ -
ATPase, and virtually undetectable levels of NHE3. In three
independent experiments, 40–60% of the hydratase activity in
basolateral membranes (Fr. 6 and 8) was resistant to
denaturation by SDS, indicating that CAIV accounts for
approximately half of the CA hydratase activity in basolateral
membranes from rabbit proximal tubule. In contrast, in
apical membrane fractions (Fr. 16–18), characterized by
abundant NHE3 and low level Na, K-ATPase (Figure 6a),
most of the hydratase activity (85–100%) was resistant to SDS
(Table 1 and Figure 6b) (note in Table 1 that in those
instances where mean hydratase activity was slightly higher in
SDS-treated apical samples compared to untreated samples,
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Figure 5 | CAIV is expressed as a single molecular weight species
in kidney cortex. (a) levels of NHE3 and Naþ ,Kþ -ATPase in the
indicated Percoll density fractions as determined by Western blotting.
Results presented are optical density values generated by
densitometric scans of film exposed to luminescence. (b) fractionated
membrane vesicles were treated with N-glycanase F or left untreated
and then resolved by SDS-PAGE. The arrow indicates the calculated
position of a putative transmembrane form of CAIV.
Table 1 | The effect of SDS treatment on hydratase activity in
membrane fractions isolated from kidney cortex
Exp. 1 Exp. 2 Exp. 3
Fraction Untreated 1% SDS Untreated 1% SDS Untreated 1% SDS
Ms CTX 91714 2078
Rb CTX 4072 3577 4774 3873 4974 4173
Fr. 6 8875 52714 9578 5077 11472 5473
Fr. 8 8574 4573 6576 4373 8972 3774
Fr.10 9178 7479 92716 85716 10174 64712
Fr.16 8575 97711 77712 7475 8877 7579
Fr.18 57716 68717 6473 7577 76710 68716
SDS, sodium dodecyl sulfate.
Results presented are the mean7s.d. for triplicate assays of hydratase activity
(EU/mg protein) determined using a microassay technique as described in Materials
and Methods. ‘Ms CTX’ denotes a total membrane fraction prepared from mouse
kidney cortex, whereas Rb CTX indicates total membrane vesicle preparations from
rabbit kidney cortex before fractionation on Percoll density gradients. Fractions 6
and 8 (Fr. 6, 8) correspond to Percoll fractions enriched for basolateral membranes,
Fr. 10 is an intermediate fraction, whereas fractions 16 and 18 are enriched for apical
membranes (Figure 6a).
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the SDS-resistant activity was deemed to be 100% (Figure
6b). Slightly increased CA activity following SDS treatment
was typically observed when boiled samples were used as a
baseline control (Exp. 1 and 2). When acetazolamide-treated
controls were used to establish baseline activity, SDS-resistant
activity did not exceed 100% (Exp. 3). The latter result is
consistent with the conclusion that CAIV is the only
membrane CA isoform expressed apically in the proximal
tubule. More importantly, these results indicate that both
CAIV and CAXII contribute to basolateral hydratase activity
that facilitates bicarbonate reabsorption in the rabbit
proximal tubule.
DISCUSSION
The principal finding of this study showed that CAIV was
expressed on both the apical and basolateral membranes of
polarized renal proximal tubular epithelial cells as a GPI-
anchored protein. We have confirmed (Figure 1) the results
of immunohistochemical studies2 by demonstrating that
proximal tubule basolateral membranes enriched from
kidney cortex contain immunoreactivity that is identical in
molecular weight to CAIV in apical membrane fractions
(Figure 5). These results rule out the possibility that
antibodies to CAIV were crossreacting with another CA
isoform (e.g. CAXII) that is expressed in basolateral
membranes of the proximal tubule. Approximately half of
the basolateral hydratase activity was resistant to SDS
denaturation (Figure 6), indicating that it was CAIV.
Furthermore, the amount of CAIV in basolateral membrane
fractions comprised a substantial portion (B30%) of the
total CAIV protein, suggesting that levels of basolaterally
expressed CAIV are sufficient for facilitation of acid/base
transport in the proximal tubule, as shown in previous
functional studies.19
In addition to CAIV reported herein, carboxypeptidase M
and PrPC are two other examples of GPI-anchored proteins
that are either targeted to both apical and basolateral
membranes (carboxypeptidase M)26 or are preferentially
sorted to basolateral membranes (PrPC)27 in MDCK cells.
Interestingly, alkaline phosphatase and five other GPI-
anchored proteins exhibited the expected apical localiza-
tion.26 In contrast, in another cell culture model, Fischer rat
thyroid epithelial cells, six out of nine detectable endogenous
GPI-anchored proteins were localized on the basolateral
surface, two were apical and one was not polarized.28
Accordingly, ours may be the first report demonstrating
both apical and basolateral targeting of a GPI-anchored
protein in polarized epithelial cells from normal tissue.
Studies utilizing a cell culture model confirmed that apical
and basolateral targeting of CAIV is an intrinsic property of
the CAIV molecule. CAIV was expressed on both apical and
basolateral membranes in transfected IMCD cells (Figure 2a),
a polarized renal epithelial cell line derived from the distal
nephron.29 In the IMCD-transfected model we also found
that CAIV expressed as transmembrane protein was prefer-
entially targeted to the basolateral membrane (Figure 2b).
Basolateral targeting of the transmembrane form of CAIV is
consistent with the presence of putative dileucine basolateral
sorting motifs within the COOH-terminal tail of CAIV.20,30
However, CAIV expressed in basolateral and apical mem-
branes from kidney cortex was equally sensitive to PI-PLC
cleavage (Figure 4), as was shown by McGwire et al.26 for
carboxypeptidase M in MDCK cells, indicating that CAIV is
expressed on both membranes as a GPI-anchored protein.
Furthermore, we found no evidence for expression of a
B3 kDa higher-molecular weight species corresponding to a
putative transmembrane form of CAIV in kidney cortex
(Figure 5). Expression of a transmembrane CAIV in the
IMCD transfectant was most likely due to exceptionally high
CAIV expression level driven by the CMV promoter of the
pcDNA 3.1 vector, which could have overloaded the capacity
of either GPI-anchor attachment or the rate of transmem-
brane form degradation in the endoplasmic reticulum.31,32
Expression of CAIV as a transmembrane protein has been
observed in normal pancreatic ducts. Fanjul et al.33 reported
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Figure 6 | CAIV contributes to hydratase activity of basolateral
membrane vesicles. Membrane vesicles prepared from kidney
cortex were fractionated on a Percoll density gradient. (a) Expression
of apical (NHE3, alkaline phosphatase) and basolateral
(Naþ ,Kþ -ATPase) membrane proteins and CAIV in the indicated
Percoll gradient fractions was determined by Western blotting and
the percentage of total NHE3, Naþ ,Kþ -ATPase, and CAIV in each
Percoll gradient fraction determined from densitometric scans of
three independent experiments. (b) The percentage of SDS-resistant
hydratase activity (corresponding to CAIV) in total membranes
isolated from mouse kidney cortex (Ms CTX), total membrane vesicles
from rabbit kidney cortex (Rb CTX), and Percoll density fractions
shown in (a).
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that CAIV expressed on the luminal or apical surface of
ductal cells was insensitive to PI-PLC cleavage and was
detected by polyclonal antisera raised against the COOH
terminal tail that is normally cleaved upon GPI-anchor
attachment. Results of this study conflict with our findings in
the IMCD transfectant model, where transmembrane CAIV
was preferentially targeted to the basolateral membrane
(Figure 2b). The functional significance of transmembrane
CAIV is unclear, as cleavage of the COOH-terminal tail of
CAIV has been reported to be necessary for realization of full
enzyme activity.34 Mutations of the o site prevented removal
of the C-terminal hydrophobic domain, such that the
mutated CAIV was inactive, not GPI-anchored, and not
expressed on the cell surface.34
Overall, the results of our study suggest that CAIV has a
strong proclivity for trafficking to the basolateral membrane
of proximal tubular epithelial cells even in the context of
GPI-anchor attachment. It is important to note, however,
that in distal nephron segments CAIV expression is detected
exclusively on the luminal or apical membrane.2 Further-
more, CAIV expressed in the rabbit kidney medulla exhibits a
distinct glycosylation pattern from CAIV expressed in kidney
cortex.2 Differences in the molecular forms and localization
of CAIV in kidney and pancreas suggest that cell-specific
post-translational modification and/or trafficking of CAIV
occurs in different types of polarized epithelial cells.
Early studies of protein trafficking indicated that GPI
anchor attachment targeted proteins to the apical membrane
of polarized epithelial cells. It was proposed that apical
sorting resulted from segregation of GPI-anchored proteins
into membrane microdomains called lipid rafts or detergent-
resistant membranes that are characterized by their lipid
composition (e.g. enriched in cholesterol and sphingolipid
content) and resistance to solubilization in non-ionic
detergents such as Triton X-100.35–40 However, it is now
clear that GPI-linkage and raft association alone is not
sufficient for apical sorting. Several studies have dissociated
apical sorting from raft association,27,41–43 and other sorting
determinants such as N-glycans42,44 or oligomerization have
been shown to exert a greater influence on apical target-
ing.45,46 Furthermore, trafficking of GPI-anchored proteins
to the apical membrane can occur via either direct or indirect
(transcytotic) pathways.41,47,48
The extent to which N-glycans, protein oligomerization,
or possibly other sorting determinants influence basolateral
sorting of CAIV in the basolateral membrane has yet to be
determined. It is interesting to speculate that CAIV
trafficking via the indirect (transcytotic) pathway results in
physical association with the sodium bicarbonate transporter,
sodium bicarbonate co-transporter 1 (NBC1) and retention
of CAIV in the basolateral membrane of the proximal tubule.
NBC1 is abundantly expressed in the basolateral membrane
of the proximal tubule where sodium-dependent co-trans-
port results in bicarbonate and fluid reabsorption.49 CAIV
has been shown to associate with NBC1 to form the
extracellular component of a bicarbonate transport meta-
bolon.50 Previous studies from our laboratory have demon-
strated the function of a basolateral, membrane-associated
CA in bicarbonate and fluid reabsorption in the proximal
tubule segments.19 Results of the this study showing
basolateral expression of CAIV in kidney cortex suggest that
GPI-anchored CAIV may facilitate bicarbonate transport by
NBC1 in the proximal tubule.
MATERIALS AND METHODS
Animals
New Zealand white rabbits were purchased from Hazelton-Dutch-
land farms (Denver, PA, USA) and maintained on a standard rabbit
diet.2 Adult rabbits (1.8–3.1 kg) were killed by intramuscular
injection with xylazine (5 mg/kg) and ketamine (44 mg/kg) followed
by an intracardiac injection of pentobarbital (100 mg/kg).
Reagents and antibodies
Recombinant PI-PLC from Bacillus thuringiensis expressed in B.
subtilis and N-glycanase (peptide-N-glycosidase F; PNGase F; EC
3.5.1.52) isolated from Escherichia coli expressing a cloned gene from
Chryseobacterium (Flavobacterium) meningosepticum were pur-
chased from Prozyme (San Leandro, CA, USA). Polyclonal goat
anti-rabbit CAIV peptide antibodies (KDNV and YDQR) were
previously produced in our laboratory2 and found not to crossreact
with rabbit CAXII.6 Monoclonal anti-Naþ ,Kþ -ATPase a-1, clone
C464.6 (Upstate Cell Signaling Solutions, Lake Placid, NY, USA),
and anti-alkaline phosphatase, tissue nonspecific (ab17973, AbCam
Inc., Cambridge, MA, USA) were used to identify basolateral and
apical GPI-anchored proteins, respectively. Monoclonal anti-NHE3
(Clone MAB3134) raised against the rabbit Naþ /Hþ exchanger 3
was purchased from Chemicon International, (Temecula, CA, USA).
Monocolonal anti-GP135 antibody was a kind gift from Dr George
Ojakian.51 HRP-conjugated secondary antibodies utilized in this
study included donkey anti-mouse, -rabbit, or -goat obtained from
Jackson ImmunoResearch, West Grove, PA, USA.
Immunohistochemical staining
Expression of CAIV in kidney sections was visualized by
immunostaining as described previously.2 Briefly, rabbit kidneys
were perfusion fixed in periodate-lysine-paraformaldehyde or a
non-formaldehyde-based fixative, Prefer (Anatech, Battle Creek, MI,
USA). Kidney slices (1–2 mm) were then incubated overnight at 41C
in the same fixative used for perfusion fixation. Sections were then
rinsed in 70% ethanol, embedded in paraffin, and 4 mm sections
were collected on slides (Superfrostþ , VWR Scientific, Piscataway,
NY, USA). After deparaffinization and hydration, antigen retrieval
was accomplished by heating slides in a microwave for 5 min in
1 mM ethylenediaminetetraacetic acid (EDTA), pH 8. Endogenous
peroxidase was quenched by incubating slides in 0.3% H2O2, and
tissue was permeabilized by treatment with 0.3% Triton X-100 in
TBS (tris-buffered saline). Slides with blocked with 10% horse
serum-TBS, and goat anti-rabbit CAIV (YDQR) antibody was
applied at a 1/125 dilution in 5% horse serum-TBS and incubated
overnight at 41C. Slides were developed by incubating with
biotinylated horse anti-goat secondary (Vector, Burlingame, CA,
USA) followed by avidin-biotinylated HRP (Vectastain Elite, Vector
Labs, Inc., Burlingame, CA, USA) according to the manufacturer’s
recommended protocol. Slides were counter-stained with hematox-
ylin according to recommended protocols (Sigma Diagnosticss,
St Louis, MO, USA). Digital Images were produced using the Spot
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RT color digital camera (Diagnostics Instruments Inc., Sterling
Heights, MI, USA) mounted on an Olympus BX51 microscope
( 60 brightfield, oil immersion) and the Spot Basic Image Software
(Diagnostic Instruments).
IMCD transfectants
Rat IMCD cells29 were grown in low-glucose Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal calf serum. 10 mM
N-2-hydroxyethylpiperazine-N0-2-ethanesulphonic acid, 2 mM
glutamine, penicillin G sodium (100 U/ml)-streptomycin sulfate
(100 mg/ml) (Invitrogen, Carlsbad, CA, USA). Full-length CAIV was
cloned into the BamHI -Xho I sites of pcDNA3 vector (Invitrogen).
In order to facilitate analysis of the molecular form of CAIV
expressed on the cell surface of IMCD cells, full-length CAIV was
subcloned into the pcDNA3.1 directional Topos Vector by
polymerase chain reaction amplification (forward: ATGCAGC
TACTGTTTGC; reverse: TCGGAGGAGGCC GGCCAT primers).
The pcDNA3.1 vector contains V5 and 6XHis epitope tags
contiguous with the CAIV sequence such that CAIV may be affinity
isolated using Ni-NTA beads (see below). Expression vectors were
transfected into IMCD cells utilizing either LipofectamineTM Reagent
GIBCO/BRLs or DOTAP liposomal transfection reagent (ROCHE
Diagnostics Corp. Indianapolis, IN, USA) according to the
manufacturer’s recommended protocols. Stable transfectants were
generated by selection with 0.8–1 mg/ml G418 2 or 3 days post-
transfection.
Biotinylation of apical versus basolateral membrane proteins
IMCD transfectants were seeded on polycarbonate Transwells
permeable supports (0.4 mM pore size) at 106/4.67 cm2 or 107/44 cm2.
The following day transepithelial resistance was measured with
an EVOMTM epithelial voltohmeter (World Precision Instruments,
Sarasota, FL, USA). Cells were washed (3 ) with ice-cold
Dulbecco’s phosphate-buffered saline (Invitrogen). Apical bio-
tinlyation was achieved by addition of 2 ml of ice-cold Dulbecco’s
phosphate-buffered saline containing 0.5 mg/ml Sulfo-NHS-
LC-Biotin (Pierce Biotechnology Inc., Rockford, IL, USA) to the
apical side (filter top) and 3 ml of Dulbecco’s phosphate-buffered
saline containing 0.5% bovine serum albumin to the basolateral
side below the filter to facilitate quenching of any biotin across
the membrane. Conversely, basolateral biotinylation was achieved
by reversing the position of the prescribed solutions. Biotinylation
reactions were incubated for 30 min at 41C and then terminated
by twice washing cells with ice-cold quenching solution
(100 mM glycine, Dulbecco’s phosphate-buffered saline) followed
by incubation with a third rinse of quenching solution for 20 min
at 41C.
Precipitation of biotinylated and/or His-tagged proteins
Precipitation of biotinylated proteins with SAv-agarose (Pierce) was
performed using IMCD transfectants lysed with ice-cold lysis buffer
(1% Triton X-100, 50 mM Tris pH 7.5, 150 mM NaCl, 5 mM EDTA
supplemented with Completes Protease Inhibitor tablets). After
0.5–1 h lysates were clarified by centrifigation at 14 000 g for
10 min, and lysates were incubated with SAv-agarose (50–100 ml of
packed beads) for 4–16 h with agitation at 41C. Beads were then
washed twice with lysis buffer, twice with high salt wash buffer
(0.1% Triton X-100, 50 mM Tris pH 7.5, 500 mM NaCl, 5 mM EDTA),
and once with 10 mM Tris pH 7.5. His-tagged proteins were
precipitated from IMCD transfectants lysed with Ni-NTA lysis
buffer (1% Triton X-100, 0.5% deoxycholate, 50 mM NaH2PO4,
300 mM NaCl, 10 mM imidazole, Completes protease inhibitor
tablets without EDTA). Clarified lysates (following centrifugation at
14 000 g for 10 min) were incubated with 100ml packed beads of
Ni-NTA-agarose (Invitrogen) 4–16 h at 41C, after which beads were
washed thrice with Ni-NTA lysis buffer. Proteins were eluted from
beads by addition of equal volume of 2 SDS-PAGE sample buffer
followed by incubation at 1001C for 5 min.
Isolation of total membranes from kidney cortex
Snap-frozen tissue (25–50 mg) was homogenized in ice-cold 1
total membrane proteins (TMP) buffer (25 mM Tris-SO4 pH 7.5,
150 mM NaCl, 1 mM EDTA) supplemented with protease inhibitor
cocktail (One CompleteR tablet per 25–50 ml buffer; Roche Applied
Science, Penzberg, Germany) and then incubated on ice for 30 min.
Cellular debris was pelleted by centrifugation at 1000 g for 10 min
at 41C. Supernatants were recovered and then total membranes were
pelleted by centrifugation at 110 000 g for 1 h at 41C. The
supernatants were decanted and pelleted membranes were resus-
pended in 100–200ml TMP buffer. Protein concentration in
membrane preparations was determined by the Bio-Rad Protein
Assay (Bio-Rad Laboratories, Hercules, CA, USA) using bovine
serum albumin as a standard.
Fractionation of membrane vesicles isolated from kidney
cortex
Basolateral membrane vesicles were enriched from rabbit kidney
cortex by Percoll density fractionation as described by Grassl and
Aronson.52 Briefly, kidney cortex (5 g) was initially homogenized
with Tekmar TK10 homogenizer in 4 (weight/volume) ice-cold
hepes-buffered sucrose with EDTA (HBE) (10 mM N-2-hydro-
xyethylpiperazine-N0-2-ethanesulphonic acid, 250 mM sucrose pH
7.6, supplemented with CompleteR Protease Inhibitor tablets) and
then Dounce homogenized (30 strokes). Homogenates were clarified
by centrifugation at 2500 g for 15 min at 41C. The supernatant was
collected, and pellets were resuspended in HBE and Dounce
homogenized for an additional 20 strokes and centrifuged
(2500 g for 15 min at 41C). Supernatants were combined and
membrane vesicles were pelleted by centrifugation (20 000 g) for
20 min. Membrane vesicles (white fluffy layer) were gently
resuspended from the pellet by aspiration, centrifuged (20 000 g)
for 20 min, and then resuspended in less than 1 ml of HBE.
Membrane vesicles were Dounce homogenized for five strokes and
0.45 ml were layered over 13.65% PercollTM (Amersham Biosciences,
Piscataway, NJ, USA) in HBE (8.5 ml) and centrifuged (48 000 g)
for 30 min. This fractionation separates basolateral from apical
membrane vesicles. Fractions (0.5–1.0 ml) were collected from
Percoll density gradients and washed with five volumes of HBE
buffer and stored at 801C until use. Total protein concentration in
each fraction was determined by utilizing the BioRad protein assay
reagent micro-method and a bovine serum albumin standard
according to recommended protocols.
PI-PLC Digestion and Triton X-114 Partitioning
Duplicates of membrane fractions (20–100 mg) were adjusted to
10 mM Tris-HCl, 144 mM NaCl by addition of appropriate volume of
5 reaction buffer and B1 mg of PI-PLC was added to one set of
duplicates and both sets were incubated overnight at 371C.
Following digestion, the sample volume was adjusted to
100–200ml with ice-cold TBS and 1/5 volume of pre-condensed
Triton X-114 (finalB2%) was added, mixed by vortexing, and then
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chilled on ice for 15 min with occasional mixing. Samples were
warmed to 371C and then centrifuged (1000 g). The upper AQ
(cleaved or non-GPI-linked protein) was separated from the DG
containing GPI-linked or transmembrane proteins. The DG was
twice back extracted with ice-cold TBS to facilitate partitioning of
soluble versus membrane-anchored proteins. Proteins were pre-
cipitated from the AQ and DGs by TCA-DOC method where 1/100
volume of 2% sodium deoxycholate was added and samples were
incubated on ice for 30 min followed by addition of 1/10 volume of
100% TCA and incubated at 41C for 16 h. Samples were then
centrifuged (15 000 g) for 15 min at 41C, and protein pellets were
washed twice with cold acetone, air-dried, and solubilized in 1
SDS-PAGE sample buffer.
Deglycosylation of CAIV
Membrane vesicles (15–25 mg total protein) prepared from kidney
cortex (see above) were adjusted to 20 mM sodium phosphate, pH
7.5, 0.02% sodium azide, 0.1% SDS, 50 mM b-mercaptoethanol, and
denatured by heating at 1001C for 5 min. Samples were allowed to
cool to room temperature and then adjusted to 0.75% NP-40. N-
glycanase (B2.5 mU) was added and reactions were incubated
overnight at 371C. Equal volume of 2 sample buffer (100 mM Tris,
pH 6.8, 20% glycerol 4% SDS, 50 mM 2-mercaptoethanol, 0.05%
bromophenol blue) was added and glycanase-treated samples were
again heated at 1001C for 5 min. Proteins were resolved on 10 or
12% SDS-PAGE gels and Western blotted for CAIV as described
below.
SDS-PAGE and Western blotting
Proteins were resolved by SDS-PAGE (8, 10, or 12% 37.5:1
Acrylamide/bis-acrylamide; Tris-glycine), and transferred to nitro-
cellulose membranes (Bio-Rad) utilizing a Panther (HEP-1) semidry
electroblotter (Owl Scientific, Cambridge, MA, USA) and Towbin’s
buffer according to recommended protocols. Membranes were then
blocked with 3% casein (EMD chemicals Inc., Gibbstown, NJ, USA)
in TBS supplemented with 0.05% Tween 20. Incubations with
primary antibodies were carried out in heat-sealable bags with 3 ml
of 1% casein TBS supplemented with 0.05% Tween 20 for 16 h at
41C, followed by 3 10 min washes with TBS supplemented with
0.05% Tween 20. Incubations with HRP-conjugated secondary
antibodies were carried for 2–4 h at room temperature and followed
by 3 10 min washes with TBS supplemented with 0.05% Tween 20
and one wash in TBS. Western blots were developed with ECLTM
chemiluminescent substrate (Amersham Biosciences), and chemi-
luminescence was detected by exposure to HyperfilmTM (Amersham)
for up to 15 min.
Microassay for quantification of CA hydratase activity in
membrane fractions
The imidazole-Tris end point assay described by Brion et al.24,25 was
used to quantify hydratase activity in membrane fractions. Briefly,
50 ml of reaction buffer (20 mM imidazole, 5 mM Tris, and 0.4 mM
p-nitrophenol) were added via Hamilton syringe to an equal volume
containing 10–30 mg of total membrane protein. Reactions were
carried out in 6 50 mm glass tubes. All reagents and samples were
chilled on ice, and all reactions were carried in a 01C ice bath. The
reaction was continuously bubbled with CO2 until the solution
acidified and the yellow color of p-nitrophenol was no longer
detectable. The CO2 flow rate was adjusted such that the time
required for color change by a water control sample was between 65
and 75 s.
Enzyme activity was expressed as EU/mg protein and was
determined using the following formula:
CA ðEU=mg proteinÞ ¼ logðB=SÞ=ðprotÞlogð2Þ;
where B is the time (s) for boiled/inactive sample and S is the sample
time. The term (prot) denotes milligrams of membrane protein in
the sample and log 2¼ 0.301. SDS-resistant activity was determined
by treating membrane samples with 1–2% SDS for 1 h at room
temperature before diluting the sample to B0.1% SDS for analysis.
For two of three experiments boiled/inactive sample hydratase
activity was determined by the time (s) for a color change in
membrane fractions that had been heated at 1001C for 15 min; for
the third experiment samples treated with 100 mM acetazolamide
established the boiled/inactive baseline time. The time required for
color change in boiled samples and acetazolamide-treated samples
were essentially equivalent (65–75 s). The baseline values for SDS-
treated samples were determined from corresponding boiled or
acetazolamide-treated samples containing equivalent concentrations
of SDS. SDS-resistant activity was divided by the activity with no
treatment to provide a percentage of CAIV activity in apical versus
basolateral fractions.
Statistics
Data are presented as mean7s.d. Paired and unpaired t-tests were
performed using Excel 2003 (Microsoft Corp., Bellvue, WA, USA).
Significance was asserted if Po0.05.
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